WhitTier Trust Company’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,820
Closed -$12.4K 1459
2025
Q1
$12.4K Hold
2,820
﹤0.01% 1072
2024
Q4
$13.1K Hold
2,820
﹤0.01% 1033
2024
Q3
$19.6K Hold
2,820
﹤0.01% 934
2024
Q2
$22K Hold
2,820
﹤0.01% 873
2024
Q1
$20K Hold
2,820
﹤0.01% 854
2023
Q4
$18.9K Hold
2,820
﹤0.01% 853
2023
Q3
$15.9K Hold
2,820
﹤0.01% 855
2023
Q2
$15.5K Hold
2,820
﹤0.01% 907
2023
Q1
$17.6K Hold
2,820
﹤0.01% 865
2022
Q4
$13.1K Hold
2,820
﹤0.01% 904
2022
Q3
$13K Hold
2,820
﹤0.01% 875
2022
Q2
$17K Buy
+2,820
New +$31.4K ﹤0.01% 838

Other funds holding GDRX

WhitTier Trust Company's GDRX Position: Q2 2025 in Review

WhitTier Trust Company sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 2,820 shares — an estimated $12.4K sold.

WhitTier Trust Company first reported a position in GDRX in Q2 2022 and held it in 12 quarters. The position peaked at $22K in Q2 2024. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • WhitTier Trust Company reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 2,820 GoodRx Holdings shares in Q2 2025, an estimated $12.4K.
  • WhitTier Trust Company first reported a position in GoodRx Holdings in Q2 2022 and held it in 12 quarters.
  • WhitTier Trust Company's GoodRx Holdings position peaked at $22K in Q2 2024.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on WhitTier Trust Company's 13F filing for Q2 2025, filed 30 Jul 2025.